Cited by 133Cannabis and Cannabinoid ResearchNeuroscience and Neuropharmacology ResearchReceptor Mechanisms and Signaling

The DOI matches its Crossref record; 114 of the 115 references it cites were found in a registry or an index.

Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release

Open access

Lee, S.-H., Ledri, M., Toth, B., Marchionni, I., Henstridge, C. M., Dudok, B., Kenesei, K., Barna, L., Szabo, S. I., Renkecz, T., Oberoi, M., Watanabe, M., Limoli, C. L., Horvai, G., Soltesz, I., Katona, I.·2015·Journal of Neuroscience

DOI 10.1523/jneurosci.4112-14.2015PMC PMC4495235

Open this paper in CoChat — free account Open PDF

Abstract

Persistent CB1 cannabinoid receptor activity limits neurotransmitter release at various synapses throughout the brain. However, it is not fully understood how constitutively active CB1 receptors, tonic endocannabinoid signaling, and its regulation by multiple serine hydrolases contribute to the synapse-specific calibration of neurotransmitter release probability. To address this question at perisomatic and dendritic GABAergic synapses in the mouse hippocampus, we used a combination of paired whole-cell patch-clamp recording, liquid chromatography/tandem mass spectrometry, stochastic optical reconstruction microscopy super-resolution imaging, and immunogold electron microscopy. Unexpectedly, application of the CB1 antagonist and inverse agonist AM251 [N-1-(2,4-dichlorophenyl)-5-(4-iodophenyl)-4-methyl-N-1-piperidinyl-1H-pyrazole-3-carboxamide], but not the neutral antagonist NESS0327 [8-chloro-1-(2,4-dichlorophenyl)-N-piperidin-1-yl-5,6-dihydro-4H-benzo[2,3]cyclohepta[2,4-b]pyrazole-3-carboxamine], significantly increased synaptic transmission between CB1-positive perisomatic interneurons and CA1 pyramidal neurons. JZL184 (4-nitrophenyl 4-[bis(1,3-benzodioxol-5-yl)(hydroxy)methyl]piperidine-1-carboxylate), a selective inhibitor of monoacylglycerol lipase (MGL), the presynaptic degrading enzyme of the endocannabinoid 2-arachidonoylglycerol (2-AG), elicited a robust increase in 2-AG levels and concomitantly decreased GABAergic transmission. In contrast, inhibition of fatty acid amide hydrolase (FAAH) by PF3845 (N-pyridin-3-yl-4-[[3-[5-(trifluoromethyl)pyridin-2-yl]oxyphenyl]methyl]piperidine-1-carboxamide) elevated endocannabinoid/endovanilloid anandamide levels but did not change GABAergic synaptic activity. However, FAAH inhibitors attenuated tonic 2-AG increase and also decreased its synaptic effects. This antagonistic interaction required the activation of the transient receptor potential vanilloid receptor TRPV1, which was concentrated on postsynaptic intracellular membrane cisternae at perisomatic GABAergic symmetrical synapses. Interestingly, neither AM251, JZL184, nor PF3845 affected CB1-positive dendritic interneuron synapses. Together, these findings are consistent with the possibility that constitutively active CB1 receptors substantially influence perisomatic GABA release probability and indicate that the synaptic effects of tonic 2-AG release are tightly controlled by presynaptic MGL activity and also by postsynaptic endovanilloid signaling and FAAH activity. SIGNIFICANCE STATEMENT: Tonic cannabinoid signaling plays a critical role in the regulation of synaptic transmission. However, the mechanistic details of how persistent CB1 cannabinoid receptor activity inhibits neurotransmitter release have remained elusive. Therefore, electrophysiological recordings, lipid measurements, and super-resolution imaging were combined to elucidate those signaling molecules and mechanisms that underlie tonic cannabinoid signaling. The findings indicate that constitutive CB1 activity has pivotal function in the tonic control of hippocampal GABA release. Moreover, the endocannabinoid 2-arachidonoylglycerol (2-AG) is continuously generated postsynaptically, but its synaptic effect is regulated strictly by presynaptic monoacylglycerol lipase activity. Finally, anandamide signaling antagonizes tonic 2-AG signaling via activation of postsynaptic transient receptor potential vanilloid TRPV1 receptors. This unexpected mechanistic diversity may be necessary to fine-tune GABA release probability under various physiological and pathophysiological conditions.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4112-14.2015

Cites

114 of 114 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Sub-diffraction-limit imaging by stochastic optical reconstruction microscopy (STORM)
Rust, M., Bates, M., & Zhuang, X. (2006) · Nature Methods · doi:10.1038/nmeth929 · Cited by 7,823
Vanilloid receptors on sensory nerves mediate the vasodilator action of anandamide
Zygmunt, P. M., Petersson, J., Andersson, D. A., Chuang, H.-H., Sørgård, M., Di Marzo, V., Julius, D., & Högestätt, E. D. (1999) · Nature · doi:10.1038/22761 · Cited by 2,142
Molecular characterization of an enzyme that degrades neuromodulatory fatty-acid amides
Cravatt, B. F., Giang, D. K., Mayfield, S. P., Boger, D. L., Lerner, R. A., & Gilula, N. B. (1996) · Nature · doi:10.1038/384083a0 · Cited by 2,125
Neuronal Diversity and Temporal Dynamics: The Unity of Hippocampal Circuit Operations
Klausberger, T., & Somogyi, P. (2008) · Science · doi:10.1126/science.1149381 · Cited by 2,050
A second endogenous cannabinoid that modulates long-term potentiation
Stella, N., Schweitzer, P., & Piomelli, D. (1997) · Nature · doi:10.1038/42015 · Cited by 1,496
Brain monoglyceride lipase participating in endocannabinoid inactivation
Dinh, T. P., Carpenter, D., Leslie, F. M., Freund, T. F., Katona, I., Sensi, S. L., Kathuria, S., & Piomelli, D. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.152334899 · Cited by 1,373
Self-citation
Modulation of anxiety through blockade of anandamide hydrolysis
Kathuria, S., Gaetani, S., Fegley, D., Valiño, F., Duranti, A., Tontini, A., Mor, M., Tarzia, G., Rana, G. L., Calignano, A., et al. (2003) · Nature Medicine · doi:10.1038/nm803 · Cited by 1,293
Presynaptically Located CB1 Cannabinoid Receptors Regulate GABA Release from Axon Terminals of Specific Hippocampal Interneurons
Katona, I., Sperlágh, B., Sı́k, A., Käfalvi, A., Vizi, E. S., Mackie, K., & Freund, T. F. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-11-04544.1999 · Cited by 1,218
Self-citation
Endocannabinoid Signaling and Synaptic Function
Castillo, P. E., Younts, T. J., Chávez, A. E., & Hashimotodani, Y. (2012) · Neuron · doi:10.1016/j.neuron.2012.09.020 · Cited by 1,191
A Comprehensive Profile of Brain Enzymes that Hydrolyze the Endocannabinoid 2-Arachidonoylglycerol
Blankman, J. L., Simon, G. M., & Cravatt, B. F. (2007) · Chemistry & Biology · doi:10.1016/j.chembiol.2007.11.006 · Cited by 1,177

Show all 115 references

Sorted by citations

Hippocampal GABAergic Inhibitory Interneurons
Pelkey, K. A., Chittajallu, R., Craig, M. T., Tricoire, L., Wester, J. C., & McBain, C. J. (2017) · Physiological Reviews · doi:10.1152/physrev.00007.2017 · Cited by 889
Cannabidiol as a Potential Treatment for Anxiety Disorders
Blessing, E., Steenkamp, M. M., Manzanares, J., & Marmar, C. R. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0387-1 · Cited by 752
From Phytocannabinoids to Cannabinoid Receptors and Endocannabinoids: Pleiotropic Physiological and Pathological Roles Through Complex Pharmacology
Ligresti, A., PETROCELLIS, L. D., & Marzo, V. D. (2016) · Physiological Reviews · doi:10.1152/physrev.00002.2016 · Cited by 505
CB1 Receptor Signaling in the Brain: Extracting Specificity from Ubiquity
Busquets-García, A., Bains, J. S., & Marsicano, G. (2017) · Neuropsychopharmacology · doi:10.1038/npp.2017.206 · Cited by 365
The cannabinoid system and pain
Woodhams, S. G., Chapman, V., Finn, D. P., Hohmann, A. G., & Neugebauer, V. (2017) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.06.015 · Cited by 285
The endocannabinoid system as a target for novel anxiolytic drugs
Patel, S., Hill, M. N., Cheer, J. F., Wotjak, C. T., & Holmes, A. (2017) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.12.033 · Cited by 233
Cannabinoid Control of Learning and Memory through HCN Channels
Maroso, M., Szabo, G. G., Kim, H. K., Alexander, A., Bui, A. D., Lee, S.-H., Lutz, B., & Soltész, I. (2016) · Neuron · doi:10.1016/j.neuron.2016.01.023 · Cited by 186
Self-citation
Don't Worry, Be Happy: Endocannabinoids and Cannabis at the Intersection of Stress and Reward
Volkow, N. D., Hampson, A. J., & Baler, R. (2016) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010716-104615 · Cited by 159
Hippocampal GABAergic interneurons and memory
Tzilivaki, A., Tukker, J. J., Maier, N., Poirazi, P., Sammons, R. P., & Schmitz, D. (2023) · Neuron · doi:10.1016/j.neuron.2023.06.016 · Cited by 154
The GABAergic Hypothesis for Cognitive Disabilities in Down Syndrome
Contestabile, A., Magara, S., & Cancedda, L. (2017) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2017.00054 · Cited by 141
The Endocannabinoid Signaling System in the CNS
Hillard, C. J. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.001 · Cited by 144
Cannabis: A Treasure Trove or Pandora's Box?
Solymosi, K., & Köfalvi, A. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161004162133 · Cited by 93
Reviewing the Role of the Endocannabinoid System in the Pathophysiology of Depression
Gallego‐Landin, I., García-Baos, A., Castro‐Zavala, A., & Valverde, O. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.762738 · Cited by 85
Glucagon-Like Peptide-1 Excites Firing and Increases GABAergic Miniature Postsynaptic Currents (mPSCs) in Gonadotropin-Releasing Hormone (GnRH) Neurons of the Male Mice via Activation of Nitric Oxide (NO) and Suppression of Endocannabinoid Signaling Pathways
Farkas, I., Vastagh, C., Farkas, E., Bálint, F., Skrapits, K., Hrabovszky, E., Fekete, C., & Liposits, Z. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00214 · Cited by 79
Cannabinoid hyperemesis syndrome: potential mechanisms for the benefit of capsaicin and hot water hydrotherapy in treatment
Richards, J. R., Lapoint, J. M., & Putze, G. B. (2017) · Clinical Toxicology · doi:10.1080/15563650.2017.1349910 · Cited by 80
Rare genetic variants in the endocannabinoid system genes CNR1 and DAGLA are associated with neurological phenotypes in humans
Smith, D. R., Stanley, C. M., Foss, T., Boles, R. G., & McKernan, K. J. (2017) · PLoS ONE · doi:10.1371/journal.pone.0187926 · Cited by 77
Endocannabinoids: Effectors of glucocorticoid signaling
Balsevich, G., Petrie, G. N., & Hill, M. N. (2017) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2017.07.005 · Cited by 82
Cannabinoid receptor type-1: breaking the dogmas
Busquets-García, A., Gómez, E. S., Bellocchio, L., & Marsicano, G. (2016) · F1000Research · doi:10.12688/f1000research.8245.1 · Cited by 79
Correlated confocal and super-resolution imaging by VividSTORM
Barna, L., Dudok, B., Miczán, V., Horváth, A., László, Z. I., & Katona, I. (2015) · Nature Protocols · doi:10.1038/nprot.2016.002 · Cited by 70
Self-citation
A role for corticotropin-releasing factor signaling in the lateral habenula and its modulation by early-life stress
Authement, M. E., Langlois, L. D., Shepard, R. D., Browne, C. A., Lucki, I., Kassis, H., & Nugent, F. S. (2018) · Science Signaling · doi:10.1126/scisignal.aan6480 · Cited by 69
Space–brain: The negative effects of space exposure on the central nervous system
Limoli, C., Jandial, R., Hoshide, R., & Waters, J. (2018) · Surgical Neurology International · doi:10.4103/sni.sni_250_17 · Cited by 66
Self-citation
Possible Therapeutic Doses of Cannabinoid Type 1 Receptor Antagonist Reverses Key Alterations in Fragile X Syndrome Mouse Model
Gomis‐González, M., Busquets-García, A., Matute, C., Maldonado, R. J., Mato, S., & Ozaita, A. (2016) · Genes · doi:10.3390/genes7090056 · Cited by 64
Mechanisms of endocannabinoid control of synaptic plasticity
Winters, B. L., & Vaughan, C. W. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108736 · Cited by 70
Suppression of Presynaptic Glutamate Release by Postsynaptic Metabotropic NMDA Receptor Signalling to Pannexin-1
Bialecki, J., Werner, A. C., Weilinger, N. L., Tucker, C. M., Vecchiarelli, H. A., Huguet, J. E., Mendizabal‐Zubiaga, J., Grandes, P., Hill, M. N., & Thompson, R. J. (2019) · Journal of Neuroscience · doi:10.1523/jneurosci.0257-19.2019 · Cited by 57
Retrograde endocannabinoid signaling at inhibitory synapses in vivo
Dudok, B., Fan, L. Z., Farrell, J. S., Malhotra, S., Homidan, J., Kim, D. K., Wenardy, C., Ramakrishnan, C., Li, Y., Deisseroth, K. A., et al. (2024) · Science · doi:10.1126/science.adk3863 · Cited by 57
Self-citation
Cyclooxygenase-2 inhibition reduces stress-induced affective pathology
Gamble-George, J. C., Baldi, R., Halladay, L., Kocharian, A., Hartley, N., Silva, C. G., Roberts, H., Haymer, A., Marnett, L. J., Holmes, A., et al. (2016) · eLife · doi:10.7554/elife.14137 · Cited by 55
TRPV1 regulates excitatory innervation of OLM neurons in the hippocampus
Hurtado-Zavala, J. I., Ramachandran, B., Ahmed, S., Halder, R., Bolleyer, C., Awasthi, A., Stahlberg, M. A., Wagener, R. J., Anderson, K., Drenan, R. M., et al. (2017) · Nature Communications · doi:10.1038/ncomms15878 · Cited by 52
Neurophysiology of space travel: energetic solar particles cause cell type-specific plasticity of neurotransmission
Lee, S.-H., Dudok, B., Parihar, V. K., Jung, K., Zöldi, M., Kang, Y., Maroso, M., Alexander, A., Nelson, G. A., Piomelli, D., et al. (2016) · Brain Structure and Function · doi:10.1007/s00429-016-1345-3 · Cited by 54
Self-citation
Endocannabinoid Signaling in Motivation, Reward, and Addiction
Sagheddu, C., Muntoni, A. L., Pistis, M., & Melis, M. (2015) · International review of neurobiology · doi:10.1016/bs.irn.2015.10.004 · Cited by 50
Cannabinoids Modulate Neuronal Activity and Cancer by CB1 and CB2 Receptor-Independent Mechanisms
Soderstrom, K., Soliman, E., & Dross, R. V. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00720 · Cited by 52
Driving the need to feed: Insight into the collaborative interaction between ghrelin and endocannabinoid systems in modulating brain reward systems
Edwards, A., & Abizaid, A. B. (2016) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2016.03.032 · Cited by 54
Endocannabinoids exert CB 1 receptor-mediated neuroprotective effects in models of neuronal damage induced by HIV-1 Tat protein
Xu, C., Hermes, D. J., Nwanguma, B., Jacobs, I. R., Mackie, K., Mukhopadhyay, S., Lichtman, A. H., Ignatowska-Jankowska, B. M., & Fitting, S. (2017) · Molecular and Cellular Neuroscience · doi:10.1016/j.mcn.2017.07.003 · Cited by 43
Inhibitions of anandamide transport and FAAH synthesis decrease apoptosis and oxidative stress through inhibition of TRPV1 channel in an in vitro seizure model
Nazıroğlu, M., Taner, A. N., Balbay, E., & Çiğ, B. (2018) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-018-3439-0 · Cited by 43
Anandamide Signaling Augmentation Rescues Amygdala Synaptic Function and Comorbid Emotional Alterations in a Model of Epilepsy
Colangeli, R., Morena, M., Pittman, Q. J., Hill, M. N., & Teskey, G. C. (2020) · Journal of Neuroscience · doi:10.1523/jneurosci.0068-20.2020 · Cited by 44
A Feedforward Inhibitory Circuit Mediated by CB1-Expressing Fast-Spiking Interneurons in the Nucleus Accumbens
Wright, W. J., Schlüter, O. M., & Dong, Y. (2016) · Neuropsychopharmacology · doi:10.1038/npp.2016.275 · Cited by 40
TRPV1 blockers as potential new treatments for psychiatric disorders
Iglesias, L. P., de Aguiar, D. C., & Moreira, F. A. (2020) · Behavioural Pharmacology · doi:10.1097/fbp.0000000000000603 · Cited by 35
Morphological and physiological properties of CCK/CB1R-expressing interneurons in the basal amygdala
Rovira-Esteban, L., Péterfi, Z., Vikór, A., Máté, Z., Szabó, G., & Hájos, N. (2017) · Brain Structure and Function · doi:10.1007/s00429-017-1417-z · Cited by 34
NECAB1 and NECAB2 are Prevalent Calcium-Binding Proteins of CB1/CCK-Positive GABAergic Interneurons
Miczán, V., Kelemen, K., Glavinics, J. R., László, Z. I., Barti, B., Kenesei, K., Kisfali, M., & Katona, I. (2020) · Cerebral Cortex · doi:10.1093/cercor/bhaa326 · Cited by 30
Self-citation
The role of the cannabinoid system in fear memory and extinction in male and female mice
Mizuno, I., Matsuda, S., Tohyama, S., & Mizutani, A. (2022) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2022.105688 · Cited by 37
Prenatal Ethanol Exposure Persistently Alters Endocannabinoid Signaling and Endocannabinoid-Mediated Excitatory Synaptic Plasticity in Ventral Tegmental Area Dopamine Neurons
Hausknecht, K. A., Shen, Y.-L., Wang, R., Haj‐Dahmane, S., & Shen, R. (2017) · Journal of Neuroscience · doi:10.1523/jneurosci.3894-16.2017 · Cited by 32
Calcium-Permeable AMPA Receptors Promote Endocannabinoid Signaling at Parvalbumin Interneuron Synapses in the Nucleus Accumbens Core
Manz, K. M., Ghose, D., Turner, B. D., Taylor, A., Becker, J. C., Grueter, C. A., & Grueter, B. A. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.107971 · Cited by 37
Multiple cannabinoid signaling cascades powerfully suppress recurrent excitation in the hippocampus
Jensen, K. R., Berthoux, C., Nasrallah, K., & Castillo, P. E. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2017590118 · Cited by 33
Transient Receptor Potential Vanilloid 1 Function at Central Synapses in Health and Disease
Meza, R. C., Ancatén-González, C., Chiu, C. Q., & Chávez, A. E. (2022) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2022.864828 · Cited by 39
Endocannabinoid Receptors in the CNS: Potential Drug Targets for the Prevention and Treatment of Neurologic and Psychiatric Disorders
Estrada, J. A., & Contreras, I. (2020) · Current Neuropharmacology · doi:10.2174/1570159x18666200217140255 · Cited by 33
Endocannabinoid-serotonin systems interaction in health and disease
Colangeli, R., Teskey, G. C., & Giovanni, G. D. (2021) · Progress in brain research · doi:10.1016/bs.pbr.2021.01.003 · Cited by 31
Vulnerability of cholecystokinin-expressing GABAergic interneurons in the unilateral intrahippocampal kainate mouse model of temporal lobe epilepsy
Kang, Y., Clement, E. M., Park, I., Greenfield, L. J., Smith, B. N., & Lee, S.-H. (2021) · Experimental Neurology · doi:10.1016/j.expneurol.2021.113724 · Cited by 31
Self-citation
Endocannabinoid Turnover
Fowler, C. J., Doherty, P., & Alexander, S. P. H. (2017) · Advances in pharmacology · doi:10.1016/bs.apha.2017.03.006 · Cited by 31
Receptome: Interactions between three pain-related receptors or the “Triumvirate” of cannabinoid, opioid and TRPV1 receptors
Zádor, F., & Wollemann, M. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2015.10.015 · Cited by 30
Estrogen Receptor Beta and 2-arachidonoylglycerol Mediate the Suppressive Effects of Estradiol on Frequency of Postsynaptic Currents in Gonadotropin-Releasing Hormone Neurons of Metestrous Mice: An Acute Slice Electrophysiological Study
Bálint, F., Liposits, Z., & Farkas, I. (2016) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2016.00077 · Cited by 30
Control of excessive neural circuit excitability and prevention of epileptic seizures by endocannabinoid signaling
Sugaya, Y., & Kano, M. (2018) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-018-2834-8 · Cited by 28
Restoring glutamate homeostasis in the nucleus accumbens via endocannabinoid-mimetic drug prevents relapse to cocaine seeking behavior in rats
Zhang, L.-Y., Zhou, Y.-Q., Yu, Z., Zhang, X., Shi, J., & Shen, H. (2021) · Neuropsychopharmacology · doi:10.1038/s41386-021-00955-1 · Cited by 30
Potentiation of microglial endocannabinoid signaling alleviates neuroinflammation in Alzheimer's disease
Rapaka, D., Bitra, V. R., Challa, S. R., & Adiukwu, P. C. (2021) · Neuropeptides · doi:10.1016/j.npep.2021.102196 · Cited by 29
Endocannabinoid-Mediated Control of Neural Circuit Excitability and Epileptic Seizures
Sugaya, Y., & Kano, M. (2022) · Frontiers in Neural Circuits · doi:10.3389/fncir.2021.781113 · Cited by 31
Acute and chronic ethanol exposure differentially regulate CB1 receptor function at glutamatergic synapses in the rat basolateral amygdala
Robinson, S. L., Alexander, N. J., Bluett, R. J., Patel, S., & McCool, B. A. (2015) · Neuropharmacology · doi:10.1016/j.neuropharm.2015.12.005 · Cited by 27
New perspectives on the role of the neurosteroid pregnenolone as an endogenous regulator of type‐1 cannabinoid receptor (CB1R) activity and function
Raux, P., Drutel, G., Revest, J., & Vallée, M. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13034 · Cited by 24
Acute administration of beta-caryophyllene prevents endocannabinoid system activation during transient common carotid artery occlusion and reperfusion
Poddighe, L., Carta, G., Serra, M. P., Melis, T., Boi, M., Lisai, S., Murru, E., Muredda, L., Collu, M., Banni, S., et al. (2018) · Lipids in Health and Disease · doi:10.1186/s12944-018-0661-4 · Cited by 28
Pharmacological effects of cannabinoids on learning and memory in Lymnaea
Sunada, H., Watanabe, T., Hatakeyama, D., Lee, S. M., Forest, J., Sakakibara, M., Ito, E., & Lukowiak, K. (2017) · Journal of Experimental Biology · doi:10.1242/jeb.159038 · Cited by 24
Self-citation
Dual pharmacological inhibitor of endocannabinoid degrading enzymes reduces depressive-like behavior in female rats
Dong, B., Shilpa, B. M., Shah, R., Goyal, A., Xie, S., Bakalian, M. J., Suckow, R. F., Cooper, T. B., Mann, J. J., Arango, V., et al. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.10.010 · Cited by 25
Chronic Pain and the Endocannabinoid System: Smart Lipids – A Novel Therapeutic Option?
Zieglgänsberger, W., Brenneisen, R., Berthele, A., Wotjak, C. T., Bandelow, B., Tölle, T. R., & Lutz, B. (2022) · Medical Cannabis and Cannabinoids · doi:10.1159/000522432 · Cited by 25
N-Oleoyl dopamine induces IL-10 via central nervous system TRPV1 and improves endotoxemia and sepsis outcomes
Joffre, J., Wong, E., Lawton, S., Lloyd, E., Nguyen, N. T., Xu, F., Sempio, C., Kobzik, L., Zlatanova, I., Schumacher, M. A., et al. (2022) · Journal of Neuroinflammation · doi:10.1186/s12974-022-02485-z · Cited by 24
Cannabinoids Occlude the HIV-1 Tat-Induced Decrease in GABAergic Neurotransmission in Prefrontal Cortex Slices
Xu, C., Hermes, D. J., Mackie, K., Lichtman, A. H., Ignatowska-Jankowska, B. M., & Fitting, S. (2016) · Journal of Neuroimmune Pharmacology · doi:10.1007/s11481-016-9664-y · Cited by 23
Inhibition of Monoacylglycerol Lipase Reduces the Reinstatement of Methamphetamine-Seeking and Anxiety-Like Behaviors in Methamphetamine Self-Administered Rats
Nawata, Y., Yamaguchi, T., Fukumori, R., & Yamamoto, T. (2018) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyy086 · Cited by 21
Axonal CB1 Receptors Mediate Inhibitory Bouton Formation via cAMP Increase and PKA
Liang, J., Kruijssen, D. L. H., Verschuuren, A. C. J., Voesenek, B. J. B., Benavides, F. F. W., González, M. S., Ruiter, M., & Wierenga, C. J. (2021) · Journal of Neuroscience · doi:10.1523/jneurosci.0851-21.2021 · Cited by 22
p21-activated kinase 1 restricts tonic endocannabinoid signaling in the hippocampus
Xia, S., Zhou, Z., Leung, C., Zhu, Y., Pan, X., Qi, J., Morena, M., Hill, M. N., Xie, W., & Jia, Z. (2016) · eLife · doi:10.7554/elife.14653 · Cited by 21
Increased TRPV1 Channels and FosB Protein Expression Are Associated with Chronic Epileptic Seizures and Anxiogenic-like Behaviors in a Preclinical Model of Temporal Lobe Epilepsy
Lazarini-Lopes, W., Silva-Cardoso, G. K., Leite‐Panissi, C. R. A., & Garcia‐Cairasco, N. (2022) · Biomedicines · doi:10.3390/biomedicines10020416 · Cited by 21
Rimonabant, a selective cannabinoid 1 receptor antagonist, protects against light-induced retinal degeneration in vitro and in vivo
Imamura, T., Tsuruma, K., Inoue, Y., Otsuka, T., Ohno, Y., Ogami, S., Yamane, S., Shimazawa, M., & Hara, H. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.03.018 · Cited by 20
Sex differences in endocannabinoid modulation of rat CA1 dendritic neurotransmission
Ferraro, A., Wig, P., Boscarino, J. J., & Reich, C. G. (2020) · Neurobiology of Stress · doi:10.1016/j.ynstr.2020.100283 · Cited by 19
2-Arachidonoylglycerol mobilization following brief synaptic stimulation in the dorsal lateral striatum requires glutamatergic and cholinergic neurotransmission
Liput, D. J., Puhl, H. L., Dong, A., He, K., Li, Y., & Lovinger, D. M. (2021) · Neuropharmacology · doi:10.1016/j.neuropharm.2021.108916 · Cited by 20
Differential Adulthood Onset mGlu5Signaling Saves Prefrontal Function in the Fragile X Mouse
Martin, H. G. S., Lassalle, O., & Manzoni, O. J. (2016) · Cerebral Cortex · doi:10.1093/cercor/bhw328 · Cited by 21
Presynaptic nanoscale components of retrograde synaptic signaling
Barti, B., Dudok, B., Kenesei, K., Zöldi, M., Miczán, V., Balla, G. Y., Zala, D., Tasso, M., Sagheddu, C., Kisfali, M., et al. (2024) · Science Advances · doi:10.1126/sciadv.ado0077 · Cited by 19
Self-citation
Expression of TRPV1 channels by Cajal‐Retzius cells and layer‐specific modulation of synaptic transmission by capsaicin in the mouse hippocampus
Anstötz, M., Lee, S. K., & Maccaferri, G. (2018) · The Journal of Physiology · doi:10.1113/jp275685 · Cited by 19
Self-citation
Tonic Endocannabinoid Signaling Gates Synaptic Plasticity in Dorsal Raphe Nucleus Serotonin Neurons Through Peroxisome Proliferator-Activated Receptors
Oubraim, S., Wang, R., Hausknecht, K. A., Shen, R., & Haj‐Dahmane, S. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2021.691219 · Cited by 18
Noncanonical Activity of Endocannabinoids and Their Receptors in Central and Peripheral Synapses
Balezina, O. P., Tarasova, E. O., & Gaydukov, A. E. (2021) · Biochemistry (Moscow) · doi:10.1134/s0006297921070038 · Cited by 18
Cell Type-specific Intrinsic Perithreshold Oscillations in Hippocampal GABAergic Interneurons
Kang, Y., Lewis, H. E. S., Young, M. W., Govindaiah, G., Greenfield, L. J., García‐Rill, E., & Lee, S.-H. (2018) · Neuroscience · doi:10.1016/j.neuroscience.2018.02.014 · Cited by 16
Self-citation
Imaging the endocannabinoid signaling system
Dudok, B., & Soltész, I. (2021) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2021.109451 · Cited by 18
Self-citation
Involvement of the endocannabinoid system in the physiological response to transient common carotid artery occlusion and reperfusion
Quartu, M., Poddighe, L., Melis, T., Serra, M. P., Boi, M., Lisai, S., Carta, G., Murru, E., Muredda, L., Collu, M., et al. (2017) · Lipids in Health and Disease · doi:10.1186/s12944-016-0389-y · Cited by 19
An inhalation anaesthesia approach for neonatal mice allowing streamlined stereotactic injection in the brain
Ho, H., Fowle, A., Coetzee, M., Greger, I. H., & Watson, J. F. (2020) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2020.108824 · Cited by 17
Insulin-Like Growth Factor 1 Increases GABAergic Neurotransmission to GnRH Neurons via Suppressing the Retrograde Tonic Endocannabinoid Signaling Pathway in Mice
Bálint, F., Csillag, V., Vastagh, C., Liposits, Z., & Farkas, I. (2020) · Neuroendocrinology · doi:10.1159/000514043 · Cited by 17
Disruption of tonic endocannabinoid signalling triggers cellular, behavioural and neuroendocrine responses consistent with a stress response
Petrie, G. N., Balsevich, G., Füzesi, T., Aukema, R. J., Driever, W. P. F., van der Stelt, M., Bains, J. S., & Hill, M. N. (2023) · British Journal of Pharmacology · doi:10.1111/bph.16198 · Cited by 19
The Absence of the Transient Receptor Potential Vanilloid 1 Directly Impacts on the Expression and Localization of the Endocannabinoid System in the Mouse Hippocampus
Huguet, J. E., Río, I. B., Gómez‐Urquijo, S., Mimenza, A., Saumell-Esnaola, M., Roman, L. B., del Caño, G. G., Sallés, J., Puente, N., Gerrikagoitia, I., et al. (2021) · Frontiers in Neuroanatomy · doi:10.3389/fnana.2021.645940 · Cited by 16
Adult Born Dentate Granule Cell Mediated Upregulation of Feedback Inhibition in a Mouse Model of Traumatic Brain Injury
Kang, Y., Lee, S.-H., Boychuk, J. A., Butler, C. R., Juras, J. A., Cloyd, R., & Smith, B. N. (2022) · Journal of Neuroscience · doi:10.1523/jneurosci.2263-21.2022 · Cited by 15
Self-citation
Toll-like receptor 4 in the interface between neuroimmune response and behavioral alterations caused by stress
de Souza-Júnior, F. J. C., Cunha, L. C., & Lisboa, S. F. D. S. (2022) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2022.00028 · Cited by 16
Endocannabinoid interactions in the regulation of acquisition of contextual conditioned fear
Balogh, Z., Szente, L., Bíró, L., Varga, Z. K., Haller, J., & Aliczki, M. (2018) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2018.11.007 · Cited by 16
Inhibitory Neurotransmission Is Sex-Dependently Affected by Tat Expression in Transgenic Mice and Suppressed by the Fatty Acid Amide Hydrolase Enzyme Inhibitor PF3845 via Cannabinoid Type-1 Receptor Mechanisms
Xu, C., Yadav-Samudrala, B. J., Xu, C., Nath, B., Mistry, T., Jiang, W., Niphakis, M. J., Cravatt, B. F., Mukhopadhyay, S., Lichtman, A. H., et al. (2022) · Cells · doi:10.3390/cells11050857 · Cited by 13
TRPV1 modulation of contextual fear memory depends on stimulus intensity and endocannabinoid signalling in the dorsal hippocampus
Iglesias, L. P., Fernandes, H. D. B., de Miranda, A. S., Pérez, M. M., Faccioli, L. H., Sorgi, C. A., Bertoglio, L. J., de Aguiar, D. C., Wotjak, C. T., & Moreira, F. A. (2022) · Neuropharmacology · doi:10.1016/j.neuropharm.2022.109314 · Cited by 15
Hierarchical glucocorticoid-endocannabinoid interplay regulates the activation of the nucleus accumbens by insulin
Pinheiro, B. S., Lemos, C., Kaufmann, F. N., Marques, J. M., da Silva-Santos, C. S., Carvalho, E., Mackie, K., Rodrigues, R. J., Cunha, R. A., & Köfalvi, A. (2016) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2016.05.009 · Cited by 13
Integrating endocannabinoid signaling, CCK interneurons, and hippocampal circuit dynamics in behaving animals
Malhotra, S., Donneger, F., Farrell, J. S., Dudok, B., Losonczy, A., & Soltész, I. (2025) · Neuron · doi:10.1016/j.neuron.2025.03.016 · Cited by 14
Self-citation
The role of the GLP-1/GLP-1R signaling pathway in regulating seizure susceptibility in rats
Zhang, Y., Fang, J., Feng, W., Sun, Q., Xu, J., & Xia, Q. (2018) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2018.06.017 · Cited by 13
Hippocampal Stratum Oriens Somatostatin-Positive Cells Undergo CB1-Dependent Long-Term Potentiation and Express Endocannabinoid Biosynthetic Enzymes
Friend, L. N., Williamson, R. C., Merrill, C. B., Newton, S. T., Christensen, M. T., Petersen, J., Wu, B., Ostlund, I., & Edwards, J. G. (2019) · Molecules · doi:10.3390/molecules24071306 · Cited by 12
An Unconventional Gabaergic Circuit Differently Controls Pyramidal Neuron Activity in Two Visual Cortical Areas Via Endocannabinoids
Koukouli, F., Montmerle, M., Aguirre, A., van Velze, M. D. B., Peixoto, J., Choudhary, V., Varilh, M., Julio‐Kalajzić, F., Allène, C., Méndez, P., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2022.111202 · Cited by 12
Electrophysiological Measurement of Cannabinoid‐Mediated Synaptic Modulation in Acute Mouse Brain Slices
Báldi, R., Ghosh, D., Grueter, B. A., & Patel, S. (2016) · Current Protocols in Neuroscience · doi:10.1002/cpns.8 · Cited by 10
The Endocannabinoid System in Prefrontal Synaptopathies
Scheyer, A. F., Martin, H. G. S., & Manzoni, O. J. (2017) · Springer eBooks · doi:10.1007/978-3-319-57371-7_7 · Cited by 10
Circuit mechanisms governing endocannabinoid modulation of affective behaviour and stress adaptation
Loomba, N., & Patel, S. (2025) · Nature reviews. Neuroscience · doi:10.1038/s41583-025-00961-y · Cited by 11
Cannabinoid and vanilloid pathways mediate opposing forms of synaptic plasticity in corticotropin‐releasing hormone neurons
Jamieson, B. B., Kim, J. S., & Iremonger, K. J. (2021) · Journal of Neuroendocrinology · doi:10.1111/jne.13084 · Cited by 9
Techniques for the Cellular and Subcellular Localization of Endocannabinoid Receptors and Enzymes in the Mammalian Brain
Cristino, L., Imperatore, R., & Marzo, V. D. (2017) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/bs.mie.2017.05.003 · Cited by 9
SGIP1 in axons prevents internalization of desensitized CB1R and modifies its function
Durydivka, O., Mackie, K., & Blahoš, J. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1213094 · Cited by 9
Loren Parsons' contribution to addiction neurobiology
Luca, M. A. D., Buczynski, M. W., & Chiara, G. D. (2018) · Addiction Biology · doi:10.1111/adb.12642 · Cited by 8
Prenatal immune activation potentiates endocannabinoid-related plasticity of inhibitory synapses in the hippocampus of adolescent rat offspring
Guo, Z., Tse, Y. C., Zhang, Y., Sun, Q., Vecchiarelli, H. A., Aukema, R. J., Hill, M. N., Wong, T. P., & Boksa, P. (2018) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2018.09.003 · Cited by 9
Endocannabinoids regulate cocaine-associated memory through brain AEA–CB1R signalling activation
Li, H., Chen, R., Zhou, Y., Wang, H., Sun, L., Yang, Z., Bai, L., & Zhang, J. (2022) · Molecular Metabolism · doi:10.1016/j.molmet.2022.101597 · Cited by 8
Anandamide and 2-AG are endogenously present within the laterodorsal tegmental nucleus: Functional implications for a role of eCBs in arousal
Soni, N., Prabhala, B. K., Mehta, V., Mirza, O., & Kohlmeier, K. A. (2017) · Brain Research · doi:10.1016/j.brainres.2017.04.003 · Cited by 8

Authors: Lee, S.-H., Ledri, M., Toth, B., Marchionni, I., Henstridge, C. M., Dudok, B., Kenesei, K., Barna, L., Szabo, S. I., Renkecz, T., Oberoi, M., Watanabe, M., Limoli, C. L., Horvai, G., Soltesz, I., & Katona, I.
Affiliations: University of California, Irvine (US)
HUN-REN Institute of Experimental Medicine (HU)
Semmelweis University (HU)
Budapest University of Technology and Economics (HU)
Hokkaido University (JP)
ORCID: Lee, S.-H.
Ledri, M.
Henstridge, C. M.
Dudok, B.
Kenesei, K.
Barna, L.
Renkecz, T.
Oberoi, M.
Watanabe, M.
Limoli, C. L.
Katona, I.
Venue: Journal of Neuroscience
Publisher: Society for Neuroscience
Published: 2015-07-08
Volume: 35
Issue: 27
Pages: 10039-10057
ISSN: 0270-6474 (ISSN-L)
1529-2401
DOI: 10.1523/jneurosci.4112-14.2015
PMC: PMC4495235
OpenAlex: W1892287994
Cited by: 133
References: 115
Citations by year: 2026: 1 · 2025: 10 · 2024: 6 · 2023: 6 · 2022: 18 · 2021: 18 · 2020: 8 · 2019: 4 · 2018: 13 · 2017: 23 · 2016: 19 · 2015: 6
FWCI: 14.65
Type: journal article
Language: en
Open access: hybrid
doi.org
Licence: cc-by
Locations: Journal of Neuroscience (publishedVersion, cc-by)
PubMed Central (publishedVersion)
PubMed (publishedVersion)
Padua Research Archive (University of Padova) (submittedVersion, other-oa)
Discovery Research Portal (University of Dundee) (submittedVersion)
eScholarship (California Digital Library) (submittedVersion)
Lund University Publications (Lund University) (submittedVersion)
Edinburgh Research Explorer (University of Edinburgh) (submittedVersion, other-oa)
Padua Research Archive (University of Padova) (submittedVersion)
Funders: National Aeronautics and Space Administration (NNX10AD59G, NNX15AI22G)
Wellcome Trust (090946)
Magyar Tudományos Akadémia
National Institutes of Health (CA-62203, NS35915)
University of California, Irvine (CA-62203)
National Cancer Institute (CA 62203, P30CA062203)
National Institute of General Medical Sciences (GM-69337, T34GM069337)
National Institute of Neurological Disorders and Stroke (R29NS035915, R01NS035915, NS-35915, R37NS035915)
FP7 Ideas: European Research Council (243153)
Topics: Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Receptor Mechanisms and Signaling
Keywords: endocannabinoid signaling, CB1 receptor, tonic inhibition, GABA release, 2-arachidonoylglycerol, anandamide, monoacylglycerol lipase, fatty acid amide hydrolase, TRPV1, presynaptic inhibition, hippocampus, CA1 pyramidal neurons
MeSH terms: Animals, Arachidonic Acids, Enzyme Inhibitors, Female, gamma-Aminobutyric Acid, Glycerides, Hippocampus, Male, Mice, Inbred C57BL, Mice, Transgenic, Neurons, Piperidines, Pyrazoles, Pyridines, Synapses, Signal Transduction, Receptor, Cannabinoid, CB1, TRPV Cation Channels, Mice, Inhibitory Postsynaptic Potentials, Cannabinoid Receptor Modulators, Endocannabinoids

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Multiple Forms of Endocannabinoid and Endovanilloid Signaling Regulate the Tonic Control of GABA Release

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks